Pain medicine

Methodological and statistical characteristics of meta-analyses on spinal cord stimulation for chronic pain: a systematic review

Reg Anesth Pain MedPublished Systematic review of meta-analyses

Authors' conclusion

The study demonstrates a critically low AMSTAR-2 quality for most MAs published on the use of SCS for treating chronic pain.

Study context

Population
Meta-analyses on spinal cord stimulation (SCS) for chronic pain (pain intensity, opioid consumption and/or physical function), published January 1, 2000 through June 30, 2023Meta-analyses (MAs) appraised
Participants
25 participants
Outcome
Methodological quality of MAs (AMSTAR-2 overall quality)
Methodological detailsmethodological quality appraisal, AMSTAR-2 critical appraisal, power analysis, Search of Ovid MEDLINE(R), Ovid EMBASE, Ovid Cochrane Database of Systematic Reviews and Scopus
  • Methodological quality appraisal
  • AMSTAR-2 critical appraisal
  • Power analysis
  • Search of Ovid MEDLINE(R), Ovid EMBASE, Ovid Cochrane Database of Systematic Reviews and Scopus

Pooled result

As reported in the abstract

AMSTAR-2 overall quality

"High" quality MAs

3

"Low" quality MAs

3

"Critically low" quality MAs

19

Further pooled results

Outcomeβ (95% CI)P value
Association of publication year with AMSTAR-2 overall qualityNo association0.043 (−0.008 to 0.095)P = 0.097
Association of impact factor with AMSTAR-2 overall qualityHigher impact factor associated with higher quality0.108 (0.044–0.172)P = 0.002
Association of effect size with AMSTAR-2 overall qualityNo association−0.168 (−0.518 to 0.183)P = 0.320

Statistical power

Adequately powered (>80%) studies
3
Remaining studies underpowered (<80%)

Original publication

Methodological and statistical characteristics of meta-analyses on spinal cord stimulation for chronic pain: a systematic review. Reg Anesth Pain Med. Published 21 February 2024. doi:10.1136/rapm-2023-105249

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.